Prior to the new recommendation, at least 28 million people were eligible for anti-HIV treatment. The targets also include ensuring access to lifesaving antiretroviral therapy for 12.9 million children, pregnant women and adults by the end of 2017.
The expanded use of antiretroviral treatment is supported by recent findings from clinical trials confirming that early use of ART keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners.